Impact of age and pre-existing immunity on the induction of human antibody responses against influenza B viruses

References

• Hay AJ, Gregory V, Douglas AR, Lin YP. The evolution of human influenza viruses. Philos Trans R Soc Lond B Biol Sci. 2001;356:1861–70. doi:10.1098/rstb.2001.0999.
   PubMed Web of Science ®Google Scholar
• Osterhaus AD, Rimmelzwaan GF, Martina BE, Bestebroer TM, Fouchier RA. Influenza B virus in seals. Science. 2000;288:1051–53. doi:10.1126/science.288.5468.1051.
   PubMed Web of Science ®Google Scholar
• Ambrose CS, Levin MJ. The rationale for quadrivalent influenza vaccines. Hum Vaccin Immunother. 2012;8:81–88. doi:10.4161/hv.8.1.17623.
   PubMed Web of Science ®Google Scholar
• Vijaykrishna D, Holmes EC, Joseph U, Fourment M, Su YC, Halpin R, Lee RT, Deng YM, Gunalan V, Lin X, et al. The contrasting phylodynamics of human influenza B viruses. Elife. 2015;4:e05055. doi:10.7554/eLife.06416.
   PubMed Web of Science ®Google Scholar
• Hadfield J, Megill C, Bell SM, Huddleston J, Potter B, Callender C, Sagulenko P, Bedford T, Neher RA. Nextstrain: real-time tracking of pathogen evolution. Bioinformatics. 2018;34:4121–23. doi:10.1093/bioinformatics/bty407.
   PubMed Web of Science ®Google Scholar
• Langat P, Raghwani J, Dudas G, Bowden TA, Edwards S, Gall A, Bedford T, Rambaut A, Daniels RS, Russell CA, et al. Genome-wide evolutionary dynamics of influenza B viruses on a global scale. PLoS Pathog. 2017;13:e1006749. doi:10.1371/journal.ppat.1006749.
   PubMedGoogle Scholar
• DiazGranados CA, Dunning AJ, Kimmel M, Kirby D, Treanor J, Collins A, Pollak R, Christoff J, Earl J, Landolfi V, et al. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med. 2014;371:635–45. doi:10.1056/NEJMoa1315727.
   PubMed Web of Science ®Google Scholar
• Nunez IA, Carlock MA, Allen JD, Owino SO, Moehling KK, Nowalk P, Susick M, Diagle K, Sweeney K, Mundle S, et al. Impact of age and pre-existing influenza immune responses in humans receiving split inactivated influenza vaccine on the induction of the breadth of antibodies to influenza A strains. PLoS One. 2017;12:e0185666. doi:10.1371/journal.pone.0185666.
   PubMed Web of Science ®Google Scholar
• Organization WH, Network WGIS. Manual for the laboratory diagnosis and virological surveillance of influenza. Geneva, Switzerland: World Health Organization; 2011.
   Google Scholar
• Agency EM. 2014. Guideline on influenza vaccines: Non-clinical and clinical module [Draft], London E14 4HB (UK).
   Google Scholar
• Organization WH. The 2017–2018 WHO influenza reagent kit for identification of influenza isolates, on who collaborating center for surveillance, epidemiology and control of influenza; 2017 Nov 12. https://www.internationalreagentresource.org/Portals/6/2017-2018%20WHO%20Kit%20Insert%20FINAL%20FINAL_Oct17_1.pdf?ver=2017-10-06-144117-843.
   Google Scholar
• Kendal AP, Cate TR. Increased sensitivity and reduced specificity of hemagglutination inhibition tests with ether-treated influenza B/Singapore/222/79. J Clin Microbiol. 1983;18:930–34.
   PubMed Web of Science ®Google Scholar
• Monto AS, Malosh RE, Petrie JG, Martin ET. The doctrine of original antigenic sin: separating good from evil. J Infect Dis. 2017;215:1782–88. doi:10.1093/infdis/jix173.
   PubMed Web of Science ®Google Scholar
• Zhang A, Stacey HD, Mullarkey CE, Miller MS. Original antigenic sin: how first exposure shapes lifelong anti-influenza virus immune responses. J Immunol. 2019;202:335–40. doi:10.4049/jimmunol.1801149.
   PubMed Web of Science ®Google Scholar
• Francis T. On the doctrine of original antigenic sin. Proc Am Philos Soc. 1960;104:572–78.
   Google Scholar
• Camilloni B, Neri M, Lepri E, Iorio AM. Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages. Vaccine. 2009;27:4099–103. doi:10.1016/j.vaccine.2009.04.078.
   PubMed Web of Science ®Google Scholar
• Asahi-Ozaki Y, Yoshikawa T, Iwakura Y, Suzuki Y, Tamura S, Kurata T, Sata T. Secretory IgA antibodies provide cross-protection against infection with different strains of influenza B virus. J Med Virol. 2004;74:328–35. doi:10.1002/jmv.20173.
   PubMed Web of Science ®Google Scholar
• Pyhala R, Kleemola M, Kumpulainen V, Vartiainen E, Lappi S, Ponka A, Cantell K. Immune response to inactivated influenza virus vaccine: antibody reactivity with epidemic influenza B viruses of two highly distinct evolutionary lineages. Vaccine. 1992;10:631–36.
   PubMed Web of Science ®Google Scholar
• Levandowski RA, Regnery HL, Staton E, Burgess BG, Williams MS, Groothuis JR. Antibody responses to influenza B viruses in immunologically unprimed children. Pediatrics. 1991;88:1031–36.
   PubMed Web of Science ®Google Scholar
• Levandowski RA, Gross PA, Weksler M, Staton E, Williams MS, Bonelli J. Cross-reactive antibodies induced by a monovalent influenza B virus vaccine. J Clin Microbiol. 1991;29:1530–32.
   PubMed Web of Science ®Google Scholar
• Liu Y, Tan HX, Koutsakos M, Jegaskanda S, Esterbauer R, Tilmanis D, Aban M, Kedzierska K, Hurt AC, Kent SJ, et al. Cross-lineage protection by human antibodies binding the influenza B hemagglutinin. Nat Commun. 2019;10:324. doi:10.1038/s41467-018-08165-y.
   PubMed Web of Science ®Google Scholar
• Huang KY, Rijal P, Schimanski L, Powell TJ, Lin TY, McCauley JW, Daniels RS, Townsend AR. Focused antibody response to influenza linked to antigenic drift. J Clin Invest. 2015;125:2631–45. doi:10.1172/JCI81104.
   PubMed Web of Science ®Google Scholar
• Wang Y-F, Chang C-F, Chi C-Y, Wang H-C, Wang J-R, Su I-J. Characterization of glycan binding specificities of influenza B viruses with correlation with hemagglutinin genotypes and clinical features. J Med Virol. 2012;84:679–85. doi:10.1002/jmv.23219.
   PubMed Web of Science ®Google Scholar
• Kumlin U, Olofsson S, Dimock K, Arnberg N. Sialic acid tissue distribution and influenza virus tropism. Influenza Other Respi Viruses. 2008;2:147–54. doi:10.1111/j.1750-2659.2008.00051.x.
   PubMed Web of Science ®Google Scholar
• de Bruijn IA, Remarque EJ, Beyer WE, le Cessie S, Masurel N, Ligthart GJ. Annually repeated influenza vaccination improves humoral responses to several influenza virus strains in healthy elderly. Vaccine. 1997;15:1323–29.
   PubMed Web of Science ®Google Scholar